Skip to main content

2 articles related to "Duligotuzumab"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Clinical Trial

Published on 31 Oct 2016

Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)

in Head and Neck Cancer

Jérôme Fayette
Lori Wirth
Cristina Oprean
Anghel Udrea
Antonio Jimeno
Danny Rischin
Christopher Nutting
Paul M. Harari
Tibor Csoszi
Dana Cernea

Frontiers in Oncology

doi 10.3389/fonc.2016.00232

10,749 views
97 citations

General Commentary

Published on 13 Mar 2017

Commentary: Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)

in Head and Neck Cancer

Nabil F. Saba

Frontiers in Oncology

doi 10.3389/fonc.2017.00031

3,488 views
10 citations